Lundin Gold Inc (LUG)
Toronto Stock Exchange · Canada · prices in CAD · close of 27 Oct 2026
Key indicators
| Last close | CAD 87.34 |
|---|---|
| 52-week range | 71.51 – 130.98 |
| Return, 1 month / 3 months | −4.6% / +9.2% |
| Return, 1 year / 3 years | +6.8% / +516.4% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 55.4% |
| Worst drawdown (1 year) | -37.9% |
| Average daily value traded | 52.14M CAD |
| Dividend yield | 6.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lundin Gold Inc is a mining company that operates the Fruta del Norte gold mine in southeastern Ecuador. The underground mine produces gold in the form of concentrate and doré bars, which the company ships to smelters and refiners for further processing. Lundin Gold is based in Vancouver, Canada, and its activities centre on extracting and processing ore from that single South American deposit, with the resulting gold sold into international precious metals markets.
The shares are listed on the Toronto Stock Exchange in Canada under the code LUG, and the price on this page is in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lundin Gold Inc (LUG) trades on the Toronto Stock Exchange in Canada. It last closed at CAD 87.34 on 27 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 419 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 6.8% and over the last three months it rose 9.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 42 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -4.0% | ||
| From 52-week high | -32.1% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 9.2% | ||
| 6-month return | -3.6% | ||
| 12-month return, skipping the last month | 12.0% | ||
| Stability (higher is calmer) | 37 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 55.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.9% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 52.14M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 58 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.7% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −3.2% |
|---|---|
| 1 month | −4.6% |
| 3 months | +9.2% |
| 6 months | −3.6% |
| 1 year | +6.8% |
| 3 years | +516.4% |
| 5 years | +859.3% |
Signals
| 50-day / 200-day average | 92.56 / 90.95 |
|---|---|
| Golden / death cross (60 days) | Golden, 11 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.74 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Sep 2026 | CAD 1.5140 |
| 10 Jun 2026 | CAD 1.6490 |
| 11 Mar 2026 | CAD 1.5750 |
| 5 Dec 2025 | CAD 1.1290 |
| 10 Sep 2025 | CAD 1.0860 |
| 10 Jun 2025 | CAD 0.6260 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.